MEDTE:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF EUR Capitalisation (EUR)

ETF | Others |

Last Closing

USD 9.3472

Change

+0.02 (+0.22)%

Market Cap

N/A

Volume

2.15K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.65 (+1.39%)

USD 60.76B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+6.80 (+1.18%)

USD 13.44B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+4.74 (+1.15%)

USD 12.33B
WRD:PA HSBC MSCI World UCITS ETF

+0.43 (+1.16%)

USD 10.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+6.50 (+1.29%)

USD 8.92B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.99 (+1.19%)

USD 8.60B
WLD:PA Lyxor UCITS MSCI World D-EUR

+4.22 (+1.16%)

USD 7.71B
HHH:PA HSBC S&P 500 UCITS ETF

+0.68 (+1.17%)

USD 7.47B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.23 (+1.19%)

USD 6.81B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+2.03 (+1.24%)

USD 5.39B

ETFs Containing MEDTE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.20% 89% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.20% 89% A- 80% B-
Trailing 12 Months  
Capital Gain 9.28% 36% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.28% 35% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.51% 26% F 41% F
Dividend Return 2.51% 62% D 38% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.31% 95% A 94% A
Risk Adjusted Return 58.29% 68% D+ 65% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike